Neonatal Hypoglycemia and Brain Vulnerability

Laura Costanza De Angelis1,2, Giorgia Brigati1, Giulia Polleri1

  • 1Neonatal Intensive Care Unit, Department Mother and Child, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Insights

Neonatal hypoglycemia, a common condition, can cause severe brain damage if prolonged. Understanding cerebral glucose homeostasis and injury mechanisms is key to developing effective treatments for affected newborns.

Area of Science:

  • Neonatal medicine
  • Neuroscience
  • Biochemistry

Background:

  • Neonatal hypoglycemia is a frequent condition, often a transient metabolic adaptation after birth.
  • Factors like limited metabolic stores or increased energy expenditure can disrupt glucose homeostasis.
  • While mild hypoglycemia's effects are unclear, severe, prolonged cases are linked to cerebral damage.

Purpose of the Study:

  • To review cerebral glucose homeostasis in neonates.
  • To elucidate mechanisms of brain injury resulting from neonatal hypoglycemia.
  • To discuss potential therapeutic strategies for neonatal hypoglycemia.

Main Methods:

  • Literature review of neonatal hypoglycemia.
  • Analysis of mechanisms underlying hypoglycemia-induced neurotoxicity.
  • Synthesis of current and potential treatment approaches.

Main Results:

  • Specific brain regions show vulnerability to hypoglycemia, including the cerebral cortex, hippocampus, and caudate-putamen.
  • Hypoglycemia-induced neuronal depolarization elevates glutamate and aspartate, leading to excitotoxicity.
  • Extracellular zinc release activates poly ADP-ribose polymerase-1, contributing to neuronal death.

Conclusions:

  • Neonatal hypoglycemia poses a risk for brain injury through excitotoxicity and other mechanisms.
  • Further research into cerebral glucose regulation and neuroprotective strategies is warranted.
  • Effective management of neonatal hypoglycemia is crucial to prevent long-term neurological deficits.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
513
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
497